GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Coya Therapeutics Inc (NAS:COYA) » Definitions » Price-to-Tangible-Book

Coya Therapeutics (Coya Therapeutics) Price-to-Tangible-Book : 3.66 (As of May. 22, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Coya Therapeutics Price-to-Tangible-Book?

As of today (2024-05-22), Coya Therapeutics's share price is $8.11. Coya Therapeutics's Tangible Book per Share of Mar. 2024 for the quarter that ended in Mar. 2024 was $2.22. Hence, Coya Therapeutics's Price to Tangible Book Ratio of today is 3.66.

The historical rank and industry rank for Coya Therapeutics's Price-to-Tangible-Book or its related term are showing as below:

COYA' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.45   Med: 3.06   Max: 4.47
Current: 3.65

During the past 4 years, Coya Therapeutics's highest Price to Tangible Book Ratio was 4.47. The lowest was 2.45. And the median was 3.06.

COYA's Price-to-Tangible-Book is ranked worse than
61.9% of 1223 companies
in the Biotechnology industry
Industry Median: 2.85 vs COYA: 3.65

A closely related ratio is called PB Ratio. As of today, Coya Therapeutics's share price is $8.11. Coya Therapeutics's Book Value per Sharefor the quarter that ended in Mar. 2024 was $2.22. Hence, Coya Therapeutics's P/B Ratio of today is 3.66.


Coya Therapeutics Price-to-Tangible-Book Historical Data

The historical data trend for Coya Therapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coya Therapeutics Price-to-Tangible-Book Chart

Coya Therapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Price-to-Tangible-Book
- - - 3.00

Coya Therapeutics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Tangible-Book Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 2.45 3.06 3.79 3.00 4.47

Competitive Comparison of Coya Therapeutics's Price-to-Tangible-Book

For the Biotechnology subindustry, Coya Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coya Therapeutics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Coya Therapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Coya Therapeutics's Price-to-Tangible-Book falls into.



Coya Therapeutics Price-to-Tangible-Book Calculation

Coya Therapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book=Share Price/Tangible Book per Share (Q: Mar. 2024 )
=8.11/2.217
=3.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.


Coya Therapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Coya Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.


Coya Therapeutics (Coya Therapeutics) Business Description

Traded in Other Exchanges
N/A
Address
5850 San Felipe Street, Suite 500, Houston, TX, USA, 77057
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.
Executives
Dieter Weinand director C/O REPLIMUNE GROUP, INC., 18 COMMERCE WAY, WOBURN MA 01801
Fred Grossman officer: Chief Medical Officer C/O COYA THERAPEUTICS, INC., 5850 SAN FELIPE ST., SUITE 500, HOUSTON TX 77057
Goldstein Dov A Md director
Adrian Hepner officer: Chief Medical Officer C/O COYA THERAPEUTICS, INC., 5850 SAN FELIPE ST., SUITE 500, HOUSTON TX 77057
David S Snyder officer: Chief Financial Officer ONE SCIENCE COURT, MADISON WI 53711
Hideki Garren director C/O PROTHENA BIOSCIENCES INC, 331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO CA 94080
Anabella Villalobos director C/O COYA THERAPEUTICS, INC., 5850 SAN FELIPE ST., SUITE 500, HOUSTON TX 77057
Howard Berman director, 10 percent owner, officer: Chief Executive Officer C/O COYA THERAPEUTICS, INC., 5850 SAN FELIPE ST., SUITE 500, HOUSTON TX 77057
Ann Lee director C/O COYA THERAPEUTICS, INC., 5850 SAN FELIPE ST., SUITE 500, HOUSTON TX 77057
Bertex Llc 10 percent owner 5850 SAN FELIPE ST., SUITE 500, HOUSTON TX 77057